These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 12792024)
1. Validation of the hexose transporter of Plasmodium falciparum as a novel drug target. Joet T; Eckstein-Ludwig U; Morin C; Krishna S Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7476-9. PubMed ID: 12792024 [TBL] [Abstract][Full Text] [Related]
2. The hexose transporter of Plasmodium falciparum is a worthy drug target. Joët T; Krishna S Acta Trop; 2004 Feb; 89(3):371-4. PubMed ID: 14744563 [TBL] [Abstract][Full Text] [Related]
3. Why is the Plasmodium falciparum hexose transporter a promising new drug target? Joët T; Morin C; Fischbarg J; Louw AI; Eckstein-Ludwig U; Woodrow C; Krishna S Expert Opin Ther Targets; 2003 Oct; 7(5):593-602. PubMed ID: 14498822 [TBL] [Abstract][Full Text] [Related]
4. Interaction of O-(undec-10-en)-yl-D-glucose derivatives with the Plasmodium falciparum hexose transporter (PfHT). Ionita M; Krishna S; Léo PM; Morin C; Patel AP Bioorg Med Chem Lett; 2007 Sep; 17(17):4934-7. PubMed ID: 17587575 [TBL] [Abstract][Full Text] [Related]
5. Analysis of Plasmodium vivax hexose transporters and effects of a parasitocidal inhibitor. Joët T; Chotivanich K; Silamut K; Patel AP; Morin C; Krishna S Biochem J; 2004 Aug; 381(Pt 3):905-9. PubMed ID: 15107012 [TBL] [Abstract][Full Text] [Related]
6. Comparative characterization of hexose transporters of Plasmodium knowlesi, Plasmodium yoelii and Toxoplasma gondii highlights functional differences within the apicomplexan family. Joët T; Holterman L; Stedman TT; Kocken CH; Van Der Wel A; Thomas AW; Krishna S Biochem J; 2002 Dec; 368(Pt 3):923-9. PubMed ID: 12238947 [TBL] [Abstract][Full Text] [Related]
7. Probing structure/affinity relationships for the Plasmodium falciparum hexose transporter with glucose derivatives. Fayolle M; Ionita M; Krishna S; Morin C; Patel AP Bioorg Med Chem Lett; 2006 Mar; 16(5):1267-71. PubMed ID: 16361099 [TBL] [Abstract][Full Text] [Related]
8. Life cycle studies of the hexose transporter of Plasmodium species and genetic validation of their essentiality. Slavic K; Straschil U; Reininger L; Doerig C; Morin C; Tewari R; Krishna S Mol Microbiol; 2010 Mar; 75(6):1402-13. PubMed ID: 20132450 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of hexose transport and abrogation of pH homeostasis in the intraerythrocytic malaria parasite by an O-3-hexose derivative. Saliba KJ; Krishna S; Kirk K FEBS Lett; 2004 Jul; 570(1-3):93-6. PubMed ID: 15251446 [TBL] [Abstract][Full Text] [Related]
10. Identification of druggable small molecule antagonists of the Plasmodium falciparum hexose transporter PfHT and assessment of ligand access to the glucose permeation pathway via FLAG-mediated protein engineering. Heitmeier MR; Hresko RC; Edwards RL; Prinsen MJ; Ilagan MXG; Odom John AR; Hruz PW PLoS One; 2019; 14(5):e0216457. PubMed ID: 31071153 [TBL] [Abstract][Full Text] [Related]
11. Docking, QM/MM, and molecular dynamics simulations of the hexose transporter from Plasmodium falciparum (PfHT). Fonseca AL; Nunes RR; Braga VM; Comar M; Alves RJ; Varotti Fde P; Taranto AG J Mol Graph Model; 2016 May; 66():174-86. PubMed ID: 27131282 [TBL] [Abstract][Full Text] [Related]
12. Functional characterization of Won JY; Mazigo E; Cha SH; Han JH Front Cell Infect Microbiol; 2023; 13():1321240. PubMed ID: 38282613 [No Abstract] [Full Text] [Related]
13. Identification of Selective Inhibitors of the Plasmodium falciparum Hexose Transporter PfHT by Screening Focused Libraries of Anti-Malarial Compounds. Ortiz D; Guiguemde WA; Johnson A; Elya C; Anderson J; Clark J; Connelly M; Yang L; Min J; Sato Y; Guy RK; Landfear SM PLoS One; 2015; 10(4):e0123598. PubMed ID: 25894322 [TBL] [Abstract][Full Text] [Related]
14. [Transport proteins as drug targets in Plasmodium falciparum. New perspectives in the treatment of malaria]. Ellekvist P; Colding H Ugeskr Laeger; 2006 Mar; 168(13):1314-7. PubMed ID: 16579884 [TBL] [Abstract][Full Text] [Related]
15. A Novel Fluorescence Resonance Energy Transfer-Based Screen in High-Throughput Format To Identify Inhibitors of Malarial and Human Glucose Transporters. Kraft TE; Heitmeier MR; Putanko M; Edwards RL; Ilagan MX; Payne MA; Autry JM; Thomas DD; Odom AR; Hruz PW Antimicrob Agents Chemother; 2016 Dec; 60(12):7407-7414. PubMed ID: 27736766 [TBL] [Abstract][Full Text] [Related]
16. Cloning and functional characterization of the human GLUT7 isoform SLC2A7 from the small intestine. Li Q; Manolescu A; Ritzel M; Yao S; Slugoski M; Young JD; Chen XZ; Cheeseman CI Am J Physiol Gastrointest Liver Physiol; 2004 Jul; 287(1):G236-42. PubMed ID: 15033637 [TBL] [Abstract][Full Text] [Related]
17. Hexose permeation pathways in Plasmodium falciparum-infected erythrocytes. Woodrow CJ; Burchmore RJ; Krishna S Proc Natl Acad Sci U S A; 2000 Aug; 97(18):9931-6. PubMed ID: 10954735 [TBL] [Abstract][Full Text] [Related]
18. A constitutive pan-hexose permease for the Plasmodium life cycle and transgenic models for screening of antimalarial sugar analogs. Blume M; Hliscs M; Rodriguez-Contreras D; Sanchez M; Landfear S; Lucius R; Matuschewski K; Gupta N FASEB J; 2011 Apr; 25(4):1218-29. PubMed ID: 21169382 [TBL] [Abstract][Full Text] [Related]
19. Use of a selective inhibitor to define the chemotherapeutic potential of the plasmodial hexose transporter in different stages of the parasite's life cycle. Slavic K; Delves MJ; Prudêncio M; Talman AM; Straschil U; Derbyshire ET; Xu Z; Sinden RE; Mota MM; Morin C; Tewari R; Krishna S; Staines HM Antimicrob Agents Chemother; 2011 Jun; 55(6):2824-30. PubMed ID: 21402842 [TBL] [Abstract][Full Text] [Related]